Breast-Conserving Surgery for Early-Stage Breast Cancer
Survival Benefits
- The American Society of Clinical Oncology recommends breast-conserving surgery (BCS) with radiation therapy for early-stage breast cancer patients, as it demonstrates equal or superior survival outcomes compared to mastectomy 1, 2, 3, 4, 5
- BCS with radiation therapy may actually have better overall survival rates than mastectomy in early-stage breast cancer patients 2, 3, 4, 5
- Multiple studies confirm that patients choosing BCS have survival outcomes that are "even better (and certainly not worse)" than those treated with mastectomy 1, 6, 5
Quality of Life and Cosmetic Outcomes
- BCS provides superior cosmetic outcomes, particularly when oncoplastic techniques are employed, according to the American College of Surgeons 1, 2, 3
- Oncoplastic techniques can maintain excellent cosmesis even in technically challenging cases, as recommended by the American Society of Breast Surgeons 2, 3
Oncologic Safety
- The National Comprehensive Cancer Network states that local recurrence rates are comparable between BCS and mastectomy in prospective randomized trials 7, 8
- Current achievable local recurrence rates with BCS are extremely low, with a target of <0.25% per year, as reported by the American College of Radiology 2, 3
- Seven modern prospective randomized trials have demonstrated equivalence of BCS and mastectomy for appropriately selected patients, according to the American Cancer Society 7, 8
Technical Considerations
- The American Society of Clinical Oncology recommends margin requirements of no tumor at the inked margin for invasive cancer and >2 mm margins preferred for DCIS 1, 2, 3, 4
- Careful histological assessment of resection margins is mandatory, as stated by the College of American Pathologists 1, 2
- Marking the tumor bed with clips facilitates accurate radiation boost planning when indicated, according to the American Society for Radiation Oncology 2, 3
- Sentinel lymph node biopsy is the standard of care for axillary staging in clinically node-negative disease, as recommended by the American College of Surgeons 1, 9
When Mastectomy Remains Necessary
- Tumor size relative to breast size may preclude adequate cosmetic outcome, necessitating mastectomy, as stated by the American Society of Breast Surgeons 3
- Tumor multicentricity may require mastectomy, according to the National Comprehensive Cancer Network 3
Critical Counseling Point
- Patients who are candidates for BCS but request mastectomy must be counseled that non-high-risk patients opting for bilateral mastectomy should be informed that survival outcomes with BCS "might be even better (and certainly not worse)" than mastectomy, as recommended by the American Society of Clinical Oncology 1, 6, 5
Special Populations
- Age alone should not determine treatment recommendations, as stated by the American Geriatrics Society 9